COR
Cencora, Inc. · Healthcare · Medical Distribution
TECHSellZACKSHold
R500#333 today
$309.05
-0.24% today · +0.69% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- COR −0.24% on the last session vs SPY +0.74%: −1.0 pts of stock-specific move.
- Aftermath, big gain (Oct 1): After its 60 big gains in the past 5 years, COR typically gained 2.5% over the next month (median) and was higher 68% of the time; half the outcomes fell between -1.8% and +7.1%. An ordinary month: +2.6%. Among S&P 500 stocks after big gains, that ranks #46 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 4
Before the open · in 31 days
EPS estimate
$4.57
$4.52 to $4.62 · 10 analysts
Revenue estimate
$87.9B
$86.7B to $88.7B
Track record
8/8 beats
last 8 reports · moved ±5.7% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 BMO | 3Q2026 | $4.35 | $4.48 | +$0.13 (+3.0%) beat | $84.8B | +3.6% +3.8 vs SPY | +3.2% | +9.0% |
| May 6, 2026 BMO | 2Q2026 | $4.72 | $4.75 | +$0.03 (+0.7%) beat | $78.4B | -17.4% -18.8 vs SPY | -12.4% | -14.7% |
| Feb 4, 2026 BMO | 1Q2026 | $4.04 | $4.08 | +$0.04 (+1.0%) beat | $85.9B | -8.8% -8.3 vs SPY | -4.6% | -0.5% |
| Nov 5, 2025 BMO | 4Q2025 | $3.79 | $3.84 | +$0.05 (+1.4%) beat | $83.7B | +2.8% +2.4 vs SPY | +2.7% | +6.0% |
| Aug 6, 2025 BMO | $3.84 | $4.00 | +$0.16 (+4.2%) beat | — | -2.9% -3.7 vs SPY | -3.5% | -1.1% | |
| May 7, 2025 BMO | $4.10 | $4.42 | +$0.32 (+7.8%) beat | — | +4.7% +4.3 vs SPY | +1.6% | -4.1% | |
| Feb 5, 2025 BMO | $3.52 | $3.73 | +$0.21 (+6.0%) beat | — | +0.7% +0.3 vs SPY | +1.1% | -1.9% | |
| Nov 6, 2024 BMO | $3.23 | $3.34 | +$0.11 (+3.4%) beat | — | +4.9% +2.4 vs SPY | +1.2% | +6.3% | |
| Jul 31, 2024 BMO | $3.22 | $3.34 | +$0.12 (+3.7%) beat | — | +3.0% +1.3 vs SPY | +3.3% | +3.8% | |
| May 1, 2024 BMO | $3.69 | $3.80 | +$0.11 (+3.0%) beat | — | -4.1% -3.8 vs SPY | -4.1% | -5.2% | |
| Jan 31, 2024 BMO | $2.89 | $3.28 | +$0.39 (+13.5%) beat | — | +5.5% +7.1 vs SPY | +3.4% | +6.6% | |
| Nov 2, 2023 BMO | $2.81 | $2.86 | +$0.05 (+1.8%) beat | — | +2.6% +0.7 vs SPY | -0.6% | +5.1% | |
| Aug 2, 2023 BMO | $2.83 | $2.92 | +$0.09 (+3.2%) beat | — | +1.2% +2.6 vs SPY | -0.7% | -2.0% | |
| May 2, 2023 BMO | $3.30 | $3.50 | +$0.20 (+6.1%) beat | — | +1.4% +2.5 vs SPY | +1.0% | +0.8% | |
| Feb 1, 2023 BMO | $2.63 | $2.71 | +$0.08 (+3.0%) beat | — | -4.7% -5.7 vs SPY | -0.5% | -7.2% | |
| Nov 3, 2022 BMO | $2.57 | $2.60 | +$0.03 (+1.2%) beat | — | +2.0% +3.0 vs SPY | -1.2% | +2.2% | |
| Aug 3, 2022 BMO | $2.56 | $2.62 | +$0.06 (+2.3%) beat | — | -2.7% -4.2 vs SPY | +0.2% | +1.3% | |
| May 4, 2022 BMO | $2.92 | $3.22 | +$0.30 (+10.3%) beat | — | +4.0% +0.9 vs SPY | +1.9% | +5.9% | |
| Feb 2, 2022 BMO | $2.58 | $2.58 | $0.00 (0.0%) in line | — | -1.1% -2.1 vs SPY | -2.4% | +3.3% | |
| Nov 4, 2021 BMO | $2.36 | $2.39 | +$0.03 (+1.3%) beat | — | -1.2% -1.6 vs SPY | -1.8% | -2.0% | |
| Aug 4, 2021 BMO | $2.04 | $2.16 | +$0.12 (+5.9%) beat | — | — | — | — | |
| May 5, 2021 BMO | $2.46 | $2.53 | +$0.07 (+2.8%) beat | — | — | — | — | |
| Feb 4, 2021 BMO | $1.94 | $2.18 | +$0.24 (+12.4%) beat | — | — | — | — | |
| Nov 5, 2020 BMO | $1.87 | $1.89 | +$0.02 (+1.1%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $4.57 (10) | $4.52 – $4.62 | +19% | -0.9% | ▲1 ▼8 | $87.9B | +5% |
| Next quarter · Dec 31, 2026 | $4.60 (7) | $4.46 – $4.99 | +13% | +2.0% | ▲3 ▼2 | $89.4B | +4% |
| Current year · Sep 30, 2026 | $17.88 (14) | $17.80 – $17.93 | +12% | +0.6% | ▲10 ▼0 | $337.0B | +5% |
| Next year · Sep 30, 2027 | $19.83 (9) | $19.44 – $20.08 | +11% | +0.2% | ▲3 ▼5 | $353.0B | +5% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.